Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

To assess the efficacy, immuno & safety of 2 doses of GSK HRV vaccine at different virus concentrations in healthy infants aged 2 months & previously uninfected with HRV, concurrently given with DTPw-HBV, Hib.
Rotavirus Vaccine
444563/006
NCT00385320
Infections, Rotavirus
Phase 2
 
An annotated case report form is not available for this study. A blank case report form will be provided.
June 2015

Powered by ideaPoint, Inc.